_PRIVATE_LIMITED_344704.webp)
Phytovedic (India) Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 15-11-2024
- Paid Up Capital ₹ 0.25 M
as on 15-11-2024
- Company Age 30 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.67 Cr
as on 15-11-2024
- Satisfied Charges ₹ 2.14 Cr
as on 15-11-2024
- Revenue 82.74%
(FY 2023)
- Profit 131.51%
(FY 2023)
- Ebitda 253.47%
(FY 2023)
- Net Worth 6.68%
(FY 2023)
- Total Assets -8.24%
(FY 2023)
About Phytovedic (India)
The Corporate was formerly known as Ayurchem (India) Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.25 M.
The company currently has active open charges totaling ₹4.67 Cr. The company has closed loans amounting to ₹2.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
Bhavesh Vador and Nimish Vador serve as directors at the Company.
- CIN/LLPIN
U24230MH1994PTC078732
- Company No.
078732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jun 1994
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Phytovedic (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavesh Vador  | Director | 02-Jun-2014 | Current |
| Nimish Vador | Director | 05-Jul-2000 | Current |
Financial Performance of Phytovedic (India).
Phytovedic (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 82.74% increase. The company also saw a substantial improvement in profitability, with a 131.51% increase in profit. The company's net worth moved up by a moderate rise of 6.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phytovedic (India)?
In 2022, Phytovedic (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jan 2024 | ₹4.50 Cr | Open |
Hdfc Bank Limited Creation Date: 08 Jul 2022 | ₹1.65 M | Open |
Hdfc Bank Limited Creation Date: 22 Jun 2018 | ₹2.14 Cr | Satisfied |
How Many Employees Work at Phytovedic (India)?
Unlock and access historical data on people associated with Phytovedic (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phytovedic (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phytovedic (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
